Loading...
BIOENGINEERING AND MEDTECH AGAINST CANCER
To meet the challenges in healthcare of the 21st century, we need to develop novel approaches by combining Bioengineering and Medtech to cancer diagnosis
BIOENGINEERING & MEDTECH AGAINST CANCER PITCH
BIOENGINEERING MEDTECH AGAINST CANCER PITCH ELEVATOR SESSION (TOHEALTH) Key words: oncology, international, healthcare education, pitch elevator,
[PDF] IBEC-Bioengineering-against-Cancerpdf
workshop on “Bioengineering and Medtech against cancer” on 24 and 25th November 2020 The event was part of the ToHealth project (https://eithealth eu/
DO6 –Synopsis - B·Debate
SYNOPSIS BIOENGINEERING AND MEDTECH AGAINST CANCER Cancer is the second leading cause of death globally, and is responsible for an estimated
[PDF] headband_approved_vfpdf - B·Debate
Page 1 BIOENGINEERING AND MEDTECH AGAINST CANCER OPEN REGISTRATION November 24th ~ 25th 2020 Collaborators Powered by:
[PDF] HUMAN RESOURCES FOR MEDICAL DEVICES
3 2 2 International Federation for Medical and Biological Engineering 56 Priority medical devices for cancer management medical technology
[PDF] BIOMEDICAL ENGINEERING: ADVANCING UK HEALTHCARE
province of biomedical engineering, the discipline overall value from medical technology cancer in UK men, with over 40,000 new cases
[PDF] Educational programme - Be In Precision Medicine
Biosciences and Bioengineering Innovations for Precision Medicine (BeInPM) 2D, 3D, and PDX: different models for studying cancer,
[PDF] Annual Report 2018-2019 - UCSD Bioengineering
focus areas that include Cancer, Cardiovascular Diseases, Hence, this technology would allow for safe, non-addictive pain relief, as it neither targets
31049_3bioengineering_medtech_against_cancer_program.pdf BIOENGINEERING AND MEDTECH
AGAINST CANCER
To meet the challenges in healthcare of the 21st century, we need to develop novel approaches by combining Bioengineering and Medtech to cancer diagnosis and prognosis. Each has a role to play in this open innovation model: clinician, engineers, industrials, entrepreneurs, doctors, MedTech companies and, of course, patients.ƚ͛ƐŝŶƚŚŝƐŽƉƚŝĐ, to bring together the different stakeholders and increase collaborations, that
the digital oncology short course will take place the 24th and 25th of November 2020 in collaboration with IBEC and the Biocat.AGENDA
DAY 1
Morning
9h00 ʹ 9h15: Opening ceremony (Medicen, Biocat, IBEC)9h15 ʹ 10h15:
(Session 1) Liquid biopsies ʹ Towards an early diagnosis and real-time monitoring of cancer (Chair: Joan Montero) o Päivi Östling - Karolinska Institutet - Finland o Julien Taieb - AP-HP, Hôpital Européen Georges Pompidou ʹ France 10h15 ʹ 10h30: Break10h30 ʹ 11h30:
(Session 2) Tumor-on-chip ʹ a 3D tool for precision oncology (Chair: Nuria Montserrat) o Stephanie Descroix - Centre de recherche de l'Institut Curie- France o Matthias Lutolf- Ecole Polytechnique Fédérale de Lausanne (EPFL) -Switzerland
Afternoon
14h00 ʹ 15h00:
(Session 3)CAR-ĐĞůůƐ͗ĞŶŐŝŶĞĞƌŝŶŐƉĂƚŝĞŶƚƐ͛ŝŵŵƵŶĞĐĞůůƐĨŽƌĐĂŶĐĞƌƚƌĞĂƚŵĞŶƚ;ŚĂŝƌ͗